Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Poniard Pharmaceuticals: A Rebound Is Overdue
Seeking Alpha
Saturday, January 23, 2010 - 11:10am
tags:
Poinard
Pfizer's Great Data Won't Do Much
Motley Fool
Saturday, January 23, 2010 - 11:09am
tags:
Pfizer, Sutent
Forest's Promising COPD Candidate
Yahoo/Zacks
Saturday, January 23, 2010 - 10:53am
tags:
Forrest, aclidinium, COPD
The Take-Away: Statins Are Still in the Cabinet
Forbes
Saturday, January 23, 2010 - 10:53am
tags:
statins
What the New MS Drug (AMPYRA) Does (and What It Doesn’t Do)
Wall Street Journal
Saturday, January 23, 2010 - 10:51am
tags:
Acorda Therapeutics, AMPYRA, multiple sclerosis
Acorda Therapeutics Announces FDA Approval of AMPYRA (dalfampridine) to Improve Walking in People with Multiple Sclerosis - Demonstrated by Increases in Walking Speed
Yahoo/Business Wire
Saturday, January 23, 2010 - 10:48am
tags:
Acorda Therapeutics, AMPYRA, multiple sclerosis
China Cord Blood, GenVec: Biggest Price Gainers (CO, GNVC)
Wall Street Journal
Saturday, January 23, 2010 - 10:47am
tags:
China Cord Blood, GenVec
Aeterna Zentaris Receives NASDAQ Notification Related to Minimum Bid Price
Yahoo/PR NewsWire
Saturday, January 23, 2010 - 10:45am
tags:
Aeterna Zentaris, financial
Extraordinary Measures: Biotech Goes to Hollywood
Wall Street Journal
Saturday, January 23, 2010 - 10:43am
tags:
biotech
Data from TNFerade(TM) Esophageal Cancer Study Presented at 2010 ASCO Gastrointestinal Cancer Symposium
Yahoo/PR NewsWire
Saturday, January 23, 2010 - 10:41am
tags:
TNFerade, esophageal cancer, GenVec
An Update on Transcept's Intermezzo
Yahoo/Zacks
Saturday, January 23, 2010 - 10:38am
tags:
Transcept, Intermezzo, insomnia
Plunging Pharmas Offer Falling Stock
Forbes
Saturday, January 23, 2010 - 10:37am
tags:
Curis, Achillion
Action Date for Genzyme's Lumizyme
Yahoo/Zacks
Saturday, January 23, 2010 - 10:32am
tags:
Genzyme, Lumizyme
2009 VC investing down, but biotech shines in Q4
Fierce Biotech
Friday, January 22, 2010 - 10:48am
tags:
venture capital, biotech
Earnings Preview: Amgen to report 4Q results
Yahoo/AP
Friday, January 22, 2010 - 10:47am
tags:
Amgen, earnings
Somaxon Pharmaceuticals Nearing End of FDA Fatigue for Silenor?
BNET Pharma
Friday, January 22, 2010 - 10:24am
tags:
FDA, Silenor, insomnia, Somaxon
Big Pharma faces tougher 2010 despite US boost
Reuters
Friday, January 22, 2010 - 10:21am
tags:
Big Pharma, earnings
Pfizer Sees Future Deals as China Biopharma Consolidates
Seeking Alpha
Friday, January 22, 2010 - 10:19am
tags:
China, Pfizer
Watson grabs market share on generic Toprol
Fierce Pharma
Friday, January 22, 2010 - 10:16am
tags:
Watson Pharmaceuticals, generics, Toprol, AstraZeneca
GSK CEO on Big Deals: ‘Paying a Premium … to Fire People’
WSJ Online
Friday, January 22, 2010 - 10:15am
tags:
Andrew Witty, GSK, M&A, Pharma CEOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.